Efficiency in COVID-19 Vaccination Campaigns-A Comparison across Germany's Federal States.
COVID-19
efficiency
vaccination campaign
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
14 Jul 2021
14 Jul 2021
Historique:
received:
27
05
2021
revised:
07
07
2021
accepted:
09
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
7
8
2021
Statut:
epublish
Résumé
Vaccination programs are considered a central pillar of the efforts to stop COVID-19. However, vaccine doses are scarce and several organizational and logistical obstacles, such as the timing of and reserves for second shots and delivery failures, apparently slow down vaccination roll-outs in several countries. Moreover, it is an open question as to where vaccines are administered as efficiently as possible (vaccination centers, hospitals, doctor's offices, pharmacists, etc.). The first aim of our study was to systematically evaluate the efficiency of a country's vaccination campaign. The second aim was to analyze how the integration of doctors' offices into a campaign that formerly relied only on vaccination centers affected the speed of that campaign. Using data on vaccine deliveries and vaccinations given in Germany, we find considerable differences across federal states in terms of efficiency, defined as the ability to administer the most vaccinations out of a given number of available doses. Back-of-the-envelope calculations for January to May 2021 show that vaccinations would have been 3.4-6.9% higher if all federal states had adopted a similar ratio between vaccinations given and vaccines stored, as the most efficient states did. This corresponds to 1.7-3.3% of Germany's total population. In terms of our second research goal, we find evidence that the integration of doctors' offices into the vaccination campaign significantly increased the ratio of vaccinations administered out of a given stock of vaccine doses. On average, there appears to be a structural break in this ratio after doctors' offices were integrated into the vaccination campaign on 5 April 2021. On average, an additional 11.6 out of 100 available doses were administered each week compared to the period prior to that date. We conclude that there are considerable regional differences in the efficiency of the vaccination roll-out. Systematic efficiency analyses are one step to detecting inefficiencies and to identify best practices that can be adopted to eventually speed up the vaccination roll-out in a country.
Identifiants
pubmed: 34358204
pii: vaccines9070788
doi: 10.3390/vaccines9070788
pmc: PMC8310303
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Rev Immunol. 2021 Apr;21(4):198-199
pubmed: 33712744
Vaccines (Basel). 2021 Apr 27;9(5):
pubmed: 33925650
Eur J Health Econ. 2013 Dec;14(6):979-94
pubmed: 23229820
Vaccine. 2021 Apr 22;39(17):2360-2365
pubmed: 33812742
Am J Public Health. 2021 Jun;111(6):1073-1077
pubmed: 33950715
Science. 2021 Feb 26;371(6532):916-921
pubmed: 33479118
MMW Fortschr Med. 2021 Apr;163(7):12-17
pubmed: 33844203
J Health Econ. 1992 Oct;11(3):279-96
pubmed: 10122540
Isr J Health Policy Res. 2021 Jan 26;10(1):6
pubmed: 33499905
One Health. 2020 Feb 24;9:100124
pubmed: 32195311
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
Lancet. 2021 May 15;397(10287):1804
pubmed: 33992137
EClinicalMedicine. 2021 Jan;31:100674
pubmed: 33319186
Isr J Health Policy Res. 2021 Feb 19;10(1):16
pubmed: 33608023
Isr J Health Policy Res. 2021 Feb 26;10(1):18
pubmed: 33637133
Isr J Health Policy Res. 2021 Jan 26;10(1):5
pubmed: 33499901
Nat Med. 2021 Jun;27(6):1055-1061
pubmed: 33875890
Int J Technol Assess Health Care. 2003 Fall;19(4):692-7
pubmed: 15095775
Nature. 2021 Feb 19;:
pubmed: 33608683
Int J Environ Res Public Health. 2020 Mar 30;17(7):
pubmed: 32235433
N Engl J Med. 2021 Jun 24;384(25):e100
pubmed: 33951377